The U.S. pediatric cancer clinical trials programmes: international implications and the way forward
about
Acute leukemia in children: A review of the current Indian dataChemotherapy drug shortages in pediatric oncology: a consensus statementHepatitis C virus infection and long-term survivors of childhood cancer: issues for the pediatric oncology nurse.Recent advances: oncologyFertility preservation and adolescent cancer patients: lessons from adult survivors of childhood cancer and their parents.Ethical issues at the interface of clinical care and research practice in pediatric oncology: a narrative review of parents' and physicians' experiences.Diet and physical activity in childhood cancer survivors: a review of the literature.Why are children with cancer being exposed to complementary medicine?Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experiencePediatric Intensive Care Unit admission criteria for haemato-oncological patients: a basis for clinical guidelines implementation.Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuseNurses' perceptions of phase I clinical trials in pediatric oncology: a review of the literature.Neurocognitive outcomes in survivors of childhood cancer.Does phase 1 trial enrollment preclude quality end-of-life care? Phase 1 trial enrollment and end-of-life care characteristics in children with cancerA public health approach to pharmacogenomics and gene-based diagnostic tests.Understanding clinical trials in childhood cancerExperience of the National Cancer Institute Community Cancer Centers Program on Community-Based Cancer Clinical Trials Activity.The crucial role of tumour specimen handling in childhood cancer outcomesDesign and recruitment of the Chicago Healthy Living Study: a study of health behaviors in a diverse cohort of adult childhood cancer survivors.Barriers and challenges to global clinical cancer researchBioconversion of pinoresinol into matairesinol by use of recombinant Escherichia coli.The successful integration of research and care: how pediatric oncology became the subspecialty in which research defines the standard of care.The use of high frequency oscillatory ventilation in a pediatric oncology intensive care unit.Clinical trial enrollment among adolescents with cancer: supplement overview.Experimental Therapeutic Trial Design for Pediatric Brain Tumors.US estimates of hospitalized pediatric patients with ulcerative colitis: implications for multicenter clinical studies.Causes of death in hospitalized children younger than 12 years of age in a Chinese hospital: a 10 year study.Developing a scale to measure parental worry and their attitudes toward childhood cancer after successful completion of treatment: a pilot study.Vulnerability: a needed moral safeguard.Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma.Outcomes of informed consent among parents of children in cancer clinical trialsEthical or Unethical Persuasion?
P2860
Q28066885-642D1838-5B13-4D23-BB09-72AA0EF33687Q28307153-91F7D866-EEEE-4DE0-9C0D-41228AB64083Q33335845-60E52E8F-56A4-44E0-979C-217998D61491Q33793871-E02A2C5F-5987-4886-BA9C-6B81AC06E53CQ34007321-5E7A2A14-EDD7-4398-8067-1679B32A1489Q34029658-C768E3E8-CC3A-4D6F-9425-19F945BAB78DQ34109270-D6162441-84F2-4998-B82C-ED67EA0F8287Q34191260-E00699CA-C314-43AE-B646-B297A1141E6AQ34781347-12F3D8C8-AF12-47B0-9F59-77B2D1F183D2Q35096943-DE3D4DCF-6E24-4290-8915-26E234BF29B6Q35661290-B97BF5E2-4C21-4062-BACF-033B18EA63EEQ35913792-3B68FE50-00C5-4485-852A-482DF53C9551Q35990012-4DD05BCF-37BD-461B-9AD2-4DB900B36980Q36389862-4B6ED522-4B90-4B78-A4EA-9E7D8E760330Q36446871-C7546472-B0EC-48B2-877B-73DEC80BA2DAQ36731847-5D204B26-E90D-47F7-98E8-0786D71713ADQ37125006-F7D3640B-38F0-4274-B9D4-4FCE368A105FQ37294008-DA48F203-A560-4437-B972-2BA1497F9EDDQ37389000-637FF4F7-101B-4234-857D-08FCB8726A94Q37519065-0A58DF87-6FD1-4414-9FC9-31195C726551Q37713102-AF99EB85-E98F-4643-9892-CDE9F4F2F313Q37833967-88C81827-B193-4455-BACE-876EFB5E7495Q37912106-1ADA188B-AF95-4DEB-B77D-2327FF4B0270Q38219434-965E9EF3-CF69-4E0C-8891-735578E48773Q38583655-4B5B7771-F13C-486E-9B7C-D8E11FBAEB81Q46762996-C0C29250-06CA-4F19-8471-E43B77AB980CQ49276441-52957D90-36A5-451C-9E09-83267354C8E0Q50626059-79C6E08D-B91E-4BDE-835A-384E61C3B4BBQ51925539-8C03E812-BCFF-4F6C-9B78-2867637D9256Q55475439-544B3E8D-530A-489F-8840-3BE5AC3C5BACQ56775976-08B9F872-471E-4304-860C-B24EB31CF72EQ59265221-F269D423-4CEE-4A8E-984A-60BE8573A04F
P2860
The U.S. pediatric cancer clinical trials programmes: international implications and the way forward
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The U.S. pediatric cancer clin ...... plications and the way forward
@ast
The U.S. pediatric cancer clin ...... plications and the way forward
@en
The U.S. pediatric cancer clin ...... plications and the way forward
@nl
type
label
The U.S. pediatric cancer clin ...... plications and the way forward
@ast
The U.S. pediatric cancer clin ...... plications and the way forward
@en
The U.S. pediatric cancer clin ...... plications and the way forward
@nl
prefLabel
The U.S. pediatric cancer clin ...... plications and the way forward
@ast
The U.S. pediatric cancer clin ...... plications and the way forward
@en
The U.S. pediatric cancer clin ...... plications and the way forward
@nl
P3181
P1476
The U.S. pediatric cancer clin ...... plications and the way forward
@en
P2093
W A Bleyer
P304
P3181
P356
10.1016/S0959-8049(97)00249-9
P407
P577
1997-08-01T00:00:00Z